Press Releases

Featured Press Releases

BIO Applauds Farm Bill Progress, Calls for …

BIO commends the leaders and members of the House and Senate Agriculture Committees on their persistence and dedication toward passing a new farm bill this year. The farm bill is vital policy that benefits all Americans, including nutrition programs…

Learn more

BIO Statement Re Updated GREET Model to Measure…

The following statement may be attributed to Beth Ellikidis, BIO's Vice President for Agriculture & Environment: “Today’s release of an updated methodology to qualify crop-based sustainable aviation fuel (SAF) for federal tax credits is a…

Learn more

Admiral William McRaven to Keynote 2024 BIO…

Retired U.S. Navy (SEAL) Four-Star Admiral and the Former Chancellor of The University of Texas System, William McRaven, to Discuss Leadership, Global Events, and the National Security Importance of Biotechnology with BIO CEO, John Crowley …

Learn more

New BIO Report Finds More Innovation & Investment Needed in Vaccine Development

January 25, 2024

Today, the Biotechnology Innovation Organization (BIO) released a new report, "The State of Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases," examining the latest scientific and investment trends in vaccine development…

BIO and ICBA Release Updated Report on Biotechnology’s Role in Meeting UN Sustainable Development Goals

December 21, 2023

The Biotechnology Innovation Organization (BIO) released an updated report produced in partnership with the International Council of Biotechnology Associations (ICBA) that highlights biotechnology’s role in meeting the United Nations’ 17 Sustainable…

BIO Applauds U.N. FAO on Food and Climate Roadmap

December 14, 2023

The Biotechnology Innovation Organization (BIO) today welcomed the United Nations (U.N.) Food and Agriculture Organization’s announcement of a new roadmap outlining how the world can attain global food security by 2050 without breaching the global…

SCOTUS should preserve FDA's "mandated authority" and "scientific and medical expertise" in new case

December 13, 2023

Today, the Supreme Court announced it will soon weigh in on a case that challenges how the Food and Drug Administration (FDA) regulates mifepristone, a drug it approved almost 25 years ago. BIO interim president and CEO, Rachel King, made the…

New Survey Finds Majority of Americans Support Incentivizing Biotech to Address Climate Change

December 8, 2023

Most Americans Recognize that Biotech Is ‘Climate Tech’ A new poll from the Biotechnology Innovation Organization (BIO) shows that majorities of Americans agree that biotech plays an important role in addressing climate change and federal…

New BIO Poll Reveals Americans Strongly Support the Orphan Cures Act

December 7, 2023

Today, the Biotechnology Innovation Organization released a poll that shows voters overwhelmingly support the ORPHAN Cures Act, a recently introduced bill that would incentivize rare disease drug development. The…

Using March-In as a Price Control Mechanism Is a “Dangerous Precedent To Set”

December 7, 2023

The White House just announced plans to use Bayh-Dole “march-in rights” to step in and license patent rights of drugs “developed with federal funding” to other manufacturers when the price of the drug is deemed too high. BIO's Chief Advocacy Officer…

Industry Leader and Globally Recognized Patient Advocate John F. Crowley Appointed to Lead BIO as President & CEO

December 5, 2023

The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President and CEO, effective March 4. He will replace Rachel King, a longtime BIO board member and…

BIO Commends USDA-APHIS Regulatory Announcements

November 21, 2023

The Department of Agriculture’s Animal and Plant Health Inspection Service recently announced exemptions from regulations under the Plant Protection Act for several categories of plants with genetic modification that could be achieved through…

BIO Statement on WHO Pandemic Accord Negotiating Draft

October 24, 2023

After the release of the World Health Organization Pandemic Accord negotiating draft, BIO's Senior Vice President of Infectious Disease & Emerging Science Policy, Phyllis Arthur, made the following remarks: “The Biotechnology Innovation…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.